The findings quantitatively confirm a reduction in IL-6, IL-8, and IL-1β expression, suppression of proliferation, and activation of apoptosis in RA-FLSs, all of which collectively lead to the regression of hyperplastic pannus and the disruption of chronic inflammatory progression. This evidence concerns the gene IL1B and rheumatoid arthritis.